Ibrahim, Humood .
HRN: 21-61-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/19/2022
12/25/2022
ORAL
4ml
Q12Hrs
AGE With Mod Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes